Literature DB >> 7694098

Carcinogenic factors in food with relevance to colon cancer development.

M Nagao1, T Sugimura.   

Abstract

The diet contains various mutagens and carcinogens that can be classified into three groups: naturally occurring chemicals, synthetic compounds and compounds produced by cooking. The first group includes mycotoxins and plant alkaloids while the second is exemplified by food additives and pesticides. The third includes polycyclic aromatic hydrocarbons and heterocyclic amines (HCAs). HCAs are mutagenic to microbes and eukaryotes and their precursors are creatine or creatinine, sugars, and amino acids in meat and fish. Among 10 HCAs so far examined for carcinogenicity in rodents, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1), 2-aminodipyrido[1,2-a:3',2'-d]imidazole (Glu-P-2), 2-amino-3-methylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced colon cancer in rats. PhIP is an especially interesting compound inducing colon tumors specifically in male F344 rats and only very rarely in females, which develop mammary carcinomas at high frequency instead. Since induced DNA adduct levels, determined by the 32P-postlabeling method, were found to be almost the same in male and female F344 rats adduct formation in itself is not directly responsible for carcinogenesis. We established, however, that PhIP causes increased cell proliferation in colon mucosa but not in the non-target liver or kidney of male rats. Induction of cell proliferation is therefore possibly an additional important factor determining carcinogenic organ specificity. In terms of molecular alteration ras family gene mutations are very rare and no mutations are evident in the p53 gene in colon tumors induced by HCAs. Their development due to HCAs can thus be considered an appropriate experimental model for human colon tumors in which ras or p53 gene activation is not involved. Since HCAs are genotoxic compounds, a causal role in some stage of human colon carcinogenesis is plausible. Exposure to HCAs should accordingly be avoided as far as possible.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694098     DOI: 10.1016/0027-5107(93)90031-a

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  17 in total

1.  Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies.

Authors:  Hong Wang; Li Ren; Yifeng He; Ye Wei; Zenggan Chen; Weige Yang; Yipeng Fu; Xiaoyue Xu; Weigao Fu; Guangfu Hu; Wenhui Lou
Journal:  Tumour Biol       Date:  2014-01-11

2.  Identification of fipronil metabolites by time-of-flight mass spectrometry for application in a human exposure study.

Authors:  Rebecca L McMahen; Mark J Strynar; Sonia Dagnino; David W Herr; Virginia C Moser; Stavros Garantziotis; Erik M Andersen; Danielle L Freeborn; Larry McMillan; Andrew B Lindstrom
Journal:  Environ Int       Date:  2015-02-17       Impact factor: 9.621

3.  Conformational differences of the C8-deoxyguanosine adduct of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) within the NarI recognition sequence.

Authors:  C Eric Elmquist; Feng Wang; James S Stover; Michael P Stone; Carmelo J Rizzo
Journal:  Chem Res Toxicol       Date:  2007-02-21       Impact factor: 3.739

Review 4.  Nutrition and colorectal cancer.

Authors:  J D Potter
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

5.  Reduction of aromatic and heterocyclic aromatic N-hydroxylamines by human cytochrome P450 2S1.

Authors:  Kai Wang; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-05-29       Impact factor: 3.739

Review 6.  Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer.

Authors:  Maya Raman; Padma Ambalam; Kanthi Kiran Kondepudi; Sheetal Pithva; Charmy Kothari; Arti T Patel; Ravi Kiran Purama; J M Dave; B R M Vyas
Journal:  Gut Microbes       Date:  2013-03-19

Review 7.  The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions.

Authors:  Abdelhakim Bouyahya; Hamza Mechchate; Loubna Oumeslakht; Ikrame Zeouk; Sara Aboulaghras; Abdelaali Balahbib; Gokhan Zengin; Mohammad Amjad Kamal; Monica Gallo; Domenico Montesano; Nasreddine El Omari
Journal:  Biomolecules       Date:  2022-02-25

8.  Meat-cooking mutagens and risk of renal cell carcinoma.

Authors:  C R Daniel; K L Schwartz; J S Colt; L M Dong; J J Ruterbusch; M P Purdue; A J Cross; N Rothman; F G Davis; S Wacholder; B I Graubard; W H Chow; R Sinha
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

Review 9.  Metabolism and biomarkers of heterocyclic aromatic amines in humans.

Authors:  Medjda Bellamri; Scott J Walmsley; Robert J Turesky
Journal:  Genes Environ       Date:  2021-07-16

10.  Quantitative assessment of the effect of cytochrome P450 2C9 gene polymorphism and colorectal cancer.

Authors:  Yuan Zhao; Yusong Han; Liang Zhang; Yichao Wang; Yushui Ma; Feng Zhang; Da Fu; Xiaofeng Wang
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.